Claus Werenberg Marcher

Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study

Gregory Cheng, Mansoor N. Saleh, Claus Werenberg Marcher et al. · The Lancet · 2010 · 574 citations · Full text

Thrombopoiesis, Thrombosis, Venous Thrombosis +12

Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study

Lene Sofie Granfeldt Østgård, Bruno C. Medeiros, Henrik Sengeløv et al. · Journal of Clinical Oncology · 2015 · 436 citations · Full text

Long term molecular responses in a cohort of Danish patients with essential thrombocythemia, polycythemia vera and myelofibrosis treated with recombinant interferon alpha

Thomas Stauffer Larsen, Katrine Fladeland Iversen, Esben Hansen et al. · Leukemia Research · 2013 · 90 citations

Inflammation, Thrombosis, Polycythemia Vera +10

Minimal residual disease and normalization of the bone marrow after long-term treatment with alpha-interferon2b in polycythemia vera. A report on molecular response patterns in seven patients in sustained complete hematological remission

Thomas Stauffer Larsen, Michael Møller, Karin de Stricker et al. · Hematology · 2009 · 82 citations

Hematological Malignancy, Polycythemia Vera, Bone Marrow Failure +15

Comorbidity and performance status in acute myeloid leukemia patients: a nation-wide population-based cohort study

Lene Sofie Granfeldt Østgård, Jan Maxwell Nørgaard, Henrik Sengeløv et al. · Leukemia · 2014 · 76 citations

Hematological Malignancy, Health Policy, Mixed-phenotype Acute Leukemia +10